Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMID 1322512)

Published in Neurology on August 01, 1992

Authors

J F Caekebeke1, M D Ferrari, C P Zwetsloot, J Jansen, P R Saxena

Author Affiliations

1: Department of Neurology, University Hospital, Leiden, The Netherlands.

Articles by these authors

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev (1994) 7.11

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell (1996) 5.99

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology (1986) 5.83

Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell (1994) 5.37

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39

Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study. Brain (2008) 3.38

Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22

Database on the structure of small ribosomal subunit RNA. Nucleic Acids Res (1997) 2.95

Cardiovascular risk factors and migraine: the GEM population-based study. Neurology (2005) 2.86

Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet (1998) 2.84

The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene (1995) 2.80

The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology (1999) 2.69

Syncope in migraine: the population-based CAMERA study. Neurology (2006) 2.33

Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2001) 2.29

Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation (1995) 2.25

The impact of migraine on quality of life in the general population: the GEM study. Neurology (2000) 2.24

Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia (2006) 2.23

Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study. Cephalalgia (2008) 2.12

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology (2000) 2.10

Associated injuries in casualties with traumatic lower extremity amputations caused by improvised explosive devices. Br J Surg (2011) 2.04

Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol (1974) 2.04

Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies". Blood (2000) 1.99

Physician-patient-companion communication and decision-making: a systematic review of triadic medical consultations. Patient Educ Couns (2013) 1.89

Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension (1994) 1.87

Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone (2001) 1.76

Stage-specific expression and genomic organization of the actin genes of the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol (1989) 1.64

Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med (1994) 1.64

Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial. Lancet (2001) 1.63

Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med (1994) 1.63

Shared genetic factors in migraine and depression: evidence from a genetic isolate. Neurology (2010) 1.61

Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun (1994) 1.57

Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation. Brain (2000) 1.56

Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia (2010) 1.56

Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet (2001) 1.54

Frozen section consultation. Utilization patterns and knowledge base of surgical faculty at a university hospital. Am J Clin Pathol (1995) 1.54

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs (2000) 1.54

Ergotamine in the acute treatment of migraine: a review and European consensus. Brain (2000) 1.52

Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch Neurol (2003) 1.51

The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut (2002) 1.50

Properties of Clarke's column neurones. Acta Physiol Scand (1969) 1.50

[Heights and weights of Danish children]. Ugeskr Laeger (1982) 1.50

Familial cyclic vomiting syndrome. Cephalalgia (2002) 1.49

The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances. Eur J Pharmacol (1971) 1.49

Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. Neurology (2000) 1.47

Features involved in the diagnostic delay of cluster headache. J Neurol Neurosurg Psychiatry (2003) 1.47

Single-fiber EMG in familial hemiplegic migraine. Neurology (2004) 1.46

Is familial hemiplegic migraine a hereditary form of basilar migraine? Cephalalgia (1995) 1.46

Cerebral vasculopathy associated with primary varicella infection. Arch Neurol (1990) 1.44

Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia (1996) 1.43

Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity. Naunyn Schmiedebergs Arch Pharmacol (1998) 1.42

Blood flow velocity changes in migraine attacks--a transcranial Doppler study. Cephalalgia (1991) 1.42

Bradykinin-induced contraction of human peripheral airways mediated by both bradykinin beta 2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med (1994) 1.41

No involvement of the calcium channel gene (CACNA1A) in a family with cluster headache. Cephalalgia (2001) 1.40

Delay in diagnosis of X-linked adrenoleukodystrophy. Clin Neurol Neurosurg (1993) 1.40

Impairment of trigeminal sensory pathways in cluster headache. Cephalalgia (2003) 1.39

Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol (2001) 1.39

[Still no proof of the efficacy of acupuncture in the prevention of migraine]. Ned Tijdschr Geneeskd (2004) 1.39

No confirmation of visual evoked potential diagnostic test for migraine. Lancet (1991) 1.39

[Radioiodine therapy for women with Graves' disease and the risk of foetal hypothyroidism if they are later found to be pregnant]. Ned Tijdschr Geneeskd (2006) 1.39

Coronary side-effect potential of current and prospective antimigraine drugs. Circulation (1998) 1.36

Hangman's fracture: arguments in favor of surgical therapy for type II and III according to Edwards and Levine. Surg Neurol (1998) 1.33

Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol (1990) 1.31

Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances. Comput Programs Biomed (1980) 1.29

Bayesian QTL analyses using pedigreed families of an outcrossing species, with application to fruit firmness in apple. Theor Appl Genet (2014) 1.27

5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br J Pharmacol (1985) 1.25

5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor. Br J Pharmacol (1988) 1.25

On serotonin and migraine: a clinical and pharmacological review. Cephalalgia (1993) 1.23

The effect of ergotamine on tissue blood flow and the arteriovenous shunting of radioactive microspheres in the head. Br J Pharmacol (1978) 1.22

Unitary components in the activation of Clarke's column neurones. Acta Physiol Scand (1969) 1.20

Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol Biochem Parasitol (1993) 1.20

Analysis of lymphoid and dendritic cells in human lymph node, tonsil and spleen. A study using monoclonal and heterologous antibodies. Virchows Arch B Cell Pathol Incl Mol Pathol (1984) 1.17

Prediction of success from a multidisciplinary treatment program for chronic low back pain. Spine (Phila Pa 1976) (1997) 1.16

Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J Physiol (1982) 1.15

Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors. Eur J Pharmacol (1970) 1.15

The effects of antimigraine drugs on the vascular responses by-5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action. Headache (1972) 1.14

Characterization of putative 5-HT7 receptors mediating tachycardia in the cat. Br J Pharmacol (1997) 1.14

Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am J Respir Crit Care Med (1994) 1.14

Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension (1997) 1.14

Emerging food-borne zoonoses. Rev Sci Tech (2004) 1.13

Quality of core collections for effective utilisation of genetic resources review, discussion and interpretation. Theor Appl Genet (2012) 1.13

Cerebral microbleeds in CADASIL. Neurology (2001) 1.13

Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine. Headache (1974) 1.12

Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia (2006) 1.11

Lifestyle-related risks: are trends in Europe converging? Public Health (2005) 1.11

Thyroid hormone transporters. Biochem Soc Trans (2005) 1.10

MRI correlates of cognitive decline in CADASIL: a 7-year follow-up study. Neurology (2009) 1.10

Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.10

Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein. J Infect Dis (1995) 1.10

Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation. Ann Neurol (2006) 1.09

Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine. Lancet (1986) 1.09

5-HT(1)-like receptor agonists and the pathophysiology of migraine. Trends Pharmacol Sci (1989) 1.09

Polarised interleukin 8 secretion by HT 29/19A cells. Gut (1994) 1.08

The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. Clin Exp Immunol (1985) 1.07

Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties. Eur J Pharmacol (1986) 1.06

Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. J Clin Endocrinol Metab (2008) 1.06

Migraine aura, illusory vertical splitting, and Picasso. Cephalalgia (2000) 1.06

Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Br J Pharmacol (1991) 1.05